TABLE 1.
Age, y, median (range) | 69 (36–90) |
Sex, male/female | 64 (50.8%)/62 (49.2%) |
Race, white/non-white | 110 (87.3%)/16 (12.7%) |
BMI, median (range) | 25.7 (14.5–38.8) |
Missing | 4 |
Smoker | |
Never | 48 (38.1%) |
Former | 66 (52.4%) |
Current | 12 (9.5%) |
Alcohol | |
Never/rare | 96 (76.2%) |
Frequent/former | 27 (21.4%) |
Missing | 3 |
Diabetes (preop) | |
No | 107 (84.9%) |
Yes | 19 (15.1%) |
Family history of PDAC | |
absent | 104 (82.5%) |
≦ 2 First-degree relatives or germline mutation | 9 (7.1%) |
BRCA2 | 2 |
STK11 | 1 |
≦ 1 First-degree relative | 7 (5.6%) |
any other FH of PDAC | 6 (4.8%) |
Previous other malignancy or neoplasm | |
No | 80 (63.5%) |
Yes | 46 (36.5%) |
Surgical procedure | |
Whipple | 90 (71.4%) |
Distal pancreatectomy | 33 (26.2%) |
Central resection | 3 (2.4%) |
Margin (original diagnostic pathology report) | |
Negative | 95 (75.4%) |
Positive | 31 (24.6%) |
Margin (pathology review for study) | |
Negative | 36 (28.6%) |
Positive* | 90 (71.4%) |
BMI indicates body mass index.
For this study, margins were considered positive if any mucinous epithelium was identified on pathology review.